{"id": 1475473332627820564, "geo": null, "lang": "en", "text": "RT @FDA_Drug_Info: Today, FDA issued a statement urging isotretinoin manufacturers to develop solutions that would minimize treatment inter\u2026", "user": {"id": 44783853, "url": "http://www.hhs.gov", "lang": null, "name": "HHS.gov", "id_str": "44783853", "location": "Washington, D.C.", "verified": true, "following": null, "protected": false, "time_zone": null, "created_at": "Fri Jun 05 01:14:31 +0000 2009", "utc_offset": null, "description": "News and information from the U.S. Department of Health & Human Services (HHS). Privacy policy: https://www.hhs.gov/privacy.html.", "geo_enabled": true, "screen_name": "HHSGov", "listed_count": 9737, "friends_count": 359, "is_translator": false, "notifications": null, "statuses_count": 26324, "default_profile": false, "followers_count": 1191771, "translator_type": "none", "favourites_count": 4345, "profile_image_url": "http://pbs.twimg.com/profile_images/567350542326718464/FXOsgyA7_normal.jpeg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/44783853/1617278422", "profile_link_color": "5FA9C2", "profile_text_color": "050505", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "withheld_in_countries": [], "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/567350542326718464/FXOsgyA7_normal.jpeg", "profile_background_color": "0F5BB1", "profile_sidebar_fill_color": "185293", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "F9FAF3", "profile_use_background_image": true, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "1475473332627820564", "source": "<a href=\"https://prod1.sprinklr.com\" rel=\"nofollow\">Sprinklr Publishing</a>", "entities": {"urls": [], "symbols": [], "hashtags": [], "user_mentions": [{"id": 53039176, "name": "FDA Drug Information", "id_str": "53039176", "indices": [3, 17], "screen_name": "FDA_Drug_Info"}]}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Mon Dec 27 14:27:10 +0000 2021", "coordinates": null, "quote_count": 0, "reply_count": 0, "contributors": null, "filter_level": "low", "timestamp_ms": "1640615230124", "retweet_count": 0, "favorite_count": 0, "is_quote_status": false, "retweeted_status": {"id": 1474136481245679624, "geo": null, "lang": "en", "text": "Today, FDA issued a statement urging isotretinoin manufacturers to develop solutions that would minimize treatment\u2026 https://t.co/4TSP1VJ94Z", "user": {"id": 53039176, "url": "http://www.fda.gov/AboutDDI", "lang": null, "name": "FDA Drug Information", "id_str": "53039176", "location": "Silver Spring", "verified": true, "following": null, "protected": false, "time_zone": null, "created_at": "Thu Jul 02 11:39:43 +0000 2009", "utc_offset": null, "description": "Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or druginfo@fda.hhs.gov. Privacy Policy - http://www.fda.gov/privacy.", "geo_enabled": false, "screen_name": "FDA_Drug_Info", "listed_count": 4325, "friends_count": 66, "is_translator": false, "notifications": null, "statuses_count": 7403, "default_profile": false, "followers_count": 331392, "translator_type": "none", "favourites_count": 128, "profile_image_url": "http://pbs.twimg.com/profile_images/774289732582903808/kU8p7iWI_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/53039176/1574833732", "profile_link_color": "29C7CC", "profile_text_color": "333333", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "withheld_in_countries": [], "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/774289732582903808/kU8p7iWI_normal.jpg", "profile_background_color": "0A0D63", "profile_sidebar_fill_color": "EFEFEF", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme14/bg.gif", "profile_sidebar_border_color": "FFFFFF", "profile_use_background_image": true, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme14/bg.gif"}, "place": null, "id_str": "1474136481245679624", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/4TSP1VJ94Z", "indices": [116, 139], "display_url": "twitter.com/i/web/status/1\u2026", "expanded_url": "https://twitter.com/i/web/status/1474136481245679624"}], "symbols": [], "hashtags": [], "user_mentions": []}, "favorited": false, "retweeted": false, "truncated": true, "created_at": "Thu Dec 23 21:54:59 +0000 2021", "coordinates": null, "quote_count": 4, "reply_count": 13, "contributors": null, "filter_level": "low", "retweet_count": 6, "extended_tweet": {"entities": {"urls": [{"url": "https://t.co/8cnUKkRngA", "indices": [189, 212], "display_url": "go.usa.gov/xeJGd", "expanded_url": "https://go.usa.gov/xeJGd"}], "media": [{"id": 1474134524070187011, "url": "https://t.co/H0rHtR7j5r", "type": "photo", "sizes": {"large": {"h": 675, "w": 1200, "resize": "fit"}, "small": {"h": 383, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 675, "w": 1200, "resize": "fit"}}, "id_str": "1474134524070187011", "indices": [213, 236], "media_url": "http://pbs.twimg.com/media/FHUtihJX0AM7rak.jpg", "description": "Text graphic. Text reads \"REMS Risk Evaluation and Mitigation Strategy\"", "display_url": "pic.twitter.com/H0rHtR7j5r", "expanded_url": "https://twitter.com/FDA_Drug_Info/status/1474136481245679624/photo/1", "media_url_https": "https://pbs.twimg.com/media/FHUtihJX0AM7rak.jpg"}], "symbols": [], "hashtags": [], "user_mentions": []}, "full_text": "Today, FDA issued a statement urging isotretinoin manufacturers to develop solutions that would minimize treatment interruptions during the transition to the modified iPLEDGE REMS program: https://t.co/8cnUKkRngA https://t.co/H0rHtR7j5r", "extended_entities": {"media": [{"id": 1474134524070187011, "url": "https://t.co/H0rHtR7j5r", "type": "photo", "sizes": {"large": {"h": 675, "w": 1200, "resize": "fit"}, "small": {"h": 383, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 675, "w": 1200, "resize": "fit"}}, "id_str": "1474134524070187011", "indices": [213, 236], "media_url": "http://pbs.twimg.com/media/FHUtihJX0AM7rak.jpg", "description": "Text graphic. Text reads \"REMS Risk Evaluation and Mitigation Strategy\"", "display_url": "pic.twitter.com/H0rHtR7j5r", "expanded_url": "https://twitter.com/FDA_Drug_Info/status/1474136481245679624/photo/1", "media_url_https": "https://pbs.twimg.com/media/FHUtihJX0AM7rak.jpg"}]}, "display_text_range": [0, 212]}, "favorite_count": 13, "is_quote_status": false, "display_text_range": [0, 140], "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}